Cti Biopharma reported $108.56M in Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Applied Genetic Technologies AGTC:US $ 20.43M 0.16M
Baxter International BAX:US $ 16686M 488M
Bristol Myers Squibb BMY:US $ 42060M 2912M
Cti Biopharma CTIC:US $ 108.56M 2.23M
Cytori Therapeutics CYTX:US $ 6.03M 0.3M
Eli Lilly And LLY:US $ 16813.8M 305M
Geron GERN:US $ 50.42M 0.24M
Mirati Therapeutics MRTX:US $ 0M 0M
Northwest Biotherapeutics NWBO:US 26.45M 1.83M
Novartis NVS:US $ 31031M 244M
Novartis NOVN:VX SF 31031M 244M
Seattle Genetics SGEN:US $ 0M 0M
Teva Pharmaceutical Industries TEVA:US $ 22082M 835M
YTE INCY:US $ 34.19M 0.01M